Regs & Eggs
Welcome to Regs and Eggs with Jeffrey Davis, ACEP’s weekly blog focused on federal regulatory (‘reg’) affairs! Every Thursday morning, there will be a new post about proposed or final regs, demonstrations, grant opportunities, other announcements from federal agencies, and ACEP's work to advocate for you.
If the weekly Regs and Eggs aren’t enough for breakfast, you can check out ACEP’s Regulatory Affairs overview for more updates.
March 30, 2023 • Opioids Info
SAMHSA and the DEA Release Guidance Regarding New Educational Requirements around the Treatment of Substance Use Disorder
Last week, I mentioned that we were waiting for the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) to release guidance on a mandatory ...
March 23, 2023 • Advocacy Info • Opioids Info
The X-Waiver is Gone… But There is a Lot More Work to do to Increase Access to Opioid Use Disorder Treatment
Many advocates of expanding access to opioid use disorder (OUD) treatment, including ACEP, rejoiced at the repeal of the “X-waiver” requirement for prescribing medications for opioid use disorder (MOU...
March 2, 2023 • Telehealth • Opioids Info
The DEA Narrowly Extends COVID-19 Telehealth Flexibilities for Prescribing Controlled Substances
Around 7 pm EST last Friday evening (February 24), the Drug Enforcement Administration (DEA) issued long-awaited proposed regulations regarding the continued use of telehealth to prescribe controlled ...
December 29, 2022 • Advocacy Info • Physician Fee Schedule • Opioids Info • Telehealth
The Congressional Year in Review: The Highs, the Lows, and Some Hard-Fought ACEP Victories
I know what you’re thinking – “this isn’t my traditional Thursday morning Regs & Eggs content, so freshly delivered.” You’re correct. Instead, it’s Ryan McBride, ACEP's Congressional Affairs Director,...
December 22, 2022 • HHS • Opioids Info • Telehealth
SAMHSA Reduces Barriers around the Treatment of Opioid Use Disorder, But More Action is Needed!
Last week, the Substance Abuse and Mental Health Services Administration (SAMHSA) within the U.S. Department of Health and Human Services (HHS) took a significant step to helping to increase access to...
December 8, 2022 • HHS • Opioids Info
Aligning 42 CFR Part 2 with HIPAA: A Work in Progress
Some of you may be familiar with an esoteric regulation called 42 CFR Part 2 (Part 2), which governs the confidentiality of patient records for the treatment of substance use disorder (SUD). Part 2 in...
September 22, 2022 • Advocacy Info • HHS • Opioids Info
HHS Releases Mental Health Roadmap; ACEP is Working on Our Own
Last Friday, the U.S. Department of Health and Human Services (HHS or the Department) released a roadmap for addressing the mental health crisis facing this country. Many of you are acutely aware of t...
April 7, 2022 • Advocacy Info • Opioids Info
Important Update on the “Three-Day” Rule for Administering Medications to Treat Opioid Use Disorder
As described in previous Regs and Eggs, there are many regulatory barriers to providing medication assisted treatment (MAT) to patients with opioid use disorder (OUD). Currently, physicians and other ...
February 17, 2022 • Advocacy Info • Opioids Info
CDC Releases Long-Awaited Revised Opioid Prescribing Guideline: Open for Public Comment
The infamous 2016 opioid prescribing guideline is finally getting a make-over. It has been a long time coming, but the Centers for Disease Control and Prevention (CDC) finally released a draft revised...
May 20, 2021 • CMS Info • Opioids Info • Telehealth
CMS Releases Medicaid Utilization Data from the COVID-19 Public Health Emergency
Medicaid and the Children’s Health Insurance Program (CHIP) cover over 100 million children, pregnant women, parents, seniors, and individuals with disabilities across the country—so it’s not a surpri...
April 29, 2021 • Advocacy Info • HHS • Opioids Info
Biden Administration Finalizes Buprenorphine Practice Guidelines: A Step in the Right Direction
The “saga” of the buprenorphine practice guidelines came to pleasant conclusion earlier this week. As you may recall, the Trump Administration released draft practice guidelines on January 14. Despit...
April 15, 2021 • Opioids Info • HHS
President Biden Releases Initial Fiscal Year 2022 Budget Proposal: Will Congress listen?
Last Friday, the Biden Administration released a portion of its fiscal year (FY) 2022 “President’s Budget.” The President’s Budget, released each year, outlines the administration’s budget and policy ...
April 8, 2021 • Advocacy Info • CMS Info • Opioids Info • HHS
Biden Administration Releases Drug Policy Priorities: What’s the Potential Impact on Emergency Care?
Last week, the Biden Administration’s Office of National Drug Control Policy (ONDCP) released its drug policy priorities for year one of the new administration. This list of priorities, which is requi...
February 11, 2021 • Advocacy Info • CMS Info • Medicare Info • Opioids Info • Physician Fee Schedule
The New Medicare Add-on Code for Medication-Assisted Treatment in the Emergency Department—Got Questions? ACEP’s Got Answers
When it comes to ACEP’s long-time goal of expanding the use of medication-assisted treatment (MAT) for the treatment of opioid use disorder (OUD), most of our attention recently has been spent on the ...
January 28, 2021 • Advocacy Info • HHS • Opioids Info
X-ing the X-Waiver: The Fight Continues!
As many of you know, as avid readers of Regs & Eggs, the U.S. Department of Health and Human Services (HHS) released practice guidelines on January 14, 2021 that created a broad exemption to the curre...
January 14, 2021 • Advocacy Info • Opioids Info
Upcoming ACEP Webinar: Learn More About Upcoming Changes to the “Three-day Rule” for Administering Medications to Treat Opioid Use Disorder
Come one, come all! On January 20 at 1:00 pm EST (right after the inauguration), I will be hosting a webinar along with Dr. Eric Ketcham (chair of ACEP’s Pain Management and Addiction Medicine Sectio...
December 10, 2020 • Advocacy Info • Opioids Info
ACEP Responds to Long-awaited DEA Regulation on EMS Controlled Substances Policies
In my last Regs & Eggs post, I highlighted the good, the bad, and the ugly in the 2021 Physician Fee Schedule (PFS) final regulation, including discussing ACEP’s response to the 6 percent Medicare pay...
December 3, 2020 • Advocacy Info • CMS Info • Physician Fee Schedule • MIPS Info • Opioids Info • Telehealth • Medicare Info
The 2021 Physician Fee Schedule Final Reg: The Good, the Bad, and the Ugly
Earlier this week, the Centers for Medicare & Medicaid Services (CMS) released the calendar year 2021 physician fee schedule (PFS) final regulation. As a reminder, this is the major annual reg that im...
October 15, 2020 • Opioids Info • CMS Info
Upcoming Medicare Requirement Around Electronic Prescribing of Controlled Substances
The SUPPORT Act—the major law passed in 2018 that addressed the opioid crisis—requires there to be electronic prescribing for controlled substances (EPCS) in the Medicare Part D Prescription Drug Prog...
August 20, 2020 • Opioids Info
Increasing Access to Naloxone
As emergency physicians, you are not only on the frontlines battling COVID-19, but for years, you have been actively trying to tackle another public health crisis facing our country: the opioid use di...
May 21, 2020 • Opioids Info
Ongoing Efforts to Reduce Barriers to Opioid Use Disorder Treatment
This week is EMS week, which gives all of us an opportunity to thank our frontline providers for their hard work and sacrifice as they have answered the call of duty during the COVID-19 pandemic.
January 30, 2020 • Opioids Info
Addressing Opioid Stigma in the Emergency Department
As emergency physicians, you have undoubtedly treated patients suffering from opioid use disorder (OUD) in the emergency department (ED). Do you view a patient with OUD differently from your patient i...
December 19, 2019 • Opioids Info
New Guidelines Coming for Prescribing Opioids to Treat Acute Pain
The Centers for Disease Control and Prevention (CDC) guideline for prescribing opioids to treat chronic pain has become a hot topic as the nation continues combating the opioid epidemic.
October 17, 2019 • Opioids Info
The Balancing Act: Addressing the Opioid Crisis vs. Exacerbating Drug Shortages
As I mentioned previously, the Trump Administration has taken numerous actions to address the opioid crisis.